Disease-Modifying Drugs For Multiple Sclerosis Not Cost-Effective At Present

Links shared publicly online about this topic.

  • 131
    total visits

Disease-Modifying Drugs For Multiple Sclerosis Not Cost-Effective At Present

medicalnewstoday.com

A new study shows that the health gains associated with a category of medications commonly used to treat Multiple Sclerosis (MS) - know as disease modifying drugs- come at a very high cost when co

View full resource at medicalnewstoday.com

Tags: Multiple Sclerosis, Disease and Condition, Drug, Healthy Living, disease

  • Share

Most Recently Shared on July 21, 2011 at 8:05 am By:

mnt_multiplescl MNT Multiple Scl

Disease-Modifying Drugs For Multiple Sclerosis Not Cost-Effective At Present http://mnt.to/3YqX #multiplesclerosis

9 months ago...

Medical News: Health Gains May Not Justify Price of MS Drugs - in Clinical Context, Multiple Sclerosis from MedPage Today

medpagetoday.com — “Disease-modifying therapies (DMTs) in multiple sclerosis may offer clinical benefits, but they are far from being cost-effective, according to a new modeling study.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on July 27, 2011 at 5:20 pm By:

MedicalFeed MedicalFeed Health News Feed

Health Gains May Not Justify Price of MS Drugs (CME/CE): (MedPage Today) -- Disease-modifying… http://goo.gl/fb/2oWah

9 months ago...

Medical News: Health Gains May Not Justify Price of MS Drugs - in Clinical Context, Multiple Sclerosis from MedPage Today

medpagetoday.com — “Disease-modifying therapies (DMTs) in multiple sclerosis may offer clinical benefits, but they are far from being cost-effective, according to a new modeling study.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on July 27, 2011 at 4:20 pm By:

MedicalNews Medical News Health News

Health Gains May Not Justify Price of MS Drugs (CME/CE) http://bit.ly/pHZksr

9 months ago...

Study: MS Drugs Help, But Come at High Cost -- American Academy of Neurology

aan.com — “A new study examining the cost-effectiveness of drugs to treat multiple sclerosis (MS) in the United States finds that the health gains from these drugs come at a very high cost compared to basic therapy to control the symptoms of MS and compared to treatments for other chronic diseases. The research is published in the July 20, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology . Disease-modifying drugs for MS became available in the 1990s. While theView full resource at aan.com

  • View Related
  • Share

Most Recently Shared on July 20, 2011 at 8:36 pm By:

Advertisement